Adenocarcinoma of the Pancreas Completed Phase 1 Trials for Sunitinib (DB01268)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00462553Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsTreatment